-
A Meta-analysis on the Association of Colibactin-producing pks+ Escherichia Coli With the Development of Colorectal Cancer
This large meta-analysis aimed to determine whether individuals carrying pks+ E. coli have a greater risk of developing colorectal cancer.
January 25, 2023
-
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine
Thrombotic thrombocytopenic purpura has been reported as a rare adverse event following COVID-19 vaccination. This paper presents a case of TTP occurring after a second dose of the BNT162b2 vaccine.
December 23, 2022
-
Use of Self-Collected Saliva Samples for the Detection of SARS-CoV-2
This study assessed the utility and diagnostic accuracy of a self-collected saliva sample type in detection of SARS-CoV-2. How did it compare to use of the standard nasopharyngeal swab?
November 23, 2022
-
Transient Pseudothrombocytopenia Detected 8 Months After COVID-19 Vaccination
This case shows that pseudothrombocytopenia may develop transiently even months after COVID-19 vaccination and should be considered when thrombocytopenia is found in recipients of the vaccine.
October 21, 2022
-
Reduced Immune Response and Neutralizing Antibody Activity to the SARS-CoV-2 Vaccination in Patients With a History of Solid Organ Transplant
How robust is the antibody response to SARS-CoV-2 vaccination in patients who have a history of solid organ or stem cell transplant?
September 21, 2022
-
Sialic Acid as a Suitable Marker of Clinical Disease Activity in Patients With Crohn's Disease
This study suggests that sialic acid may be a more sensitive and specific marker than CRP for monitoring the disease activity of patients with Crohn's disease.
August 26, 2022
-
Methods to Correct Drug-Induced Coagulopathy in Bleeding Emergencies
This review highlights the challenges of drug-induced coagulopathy as a result of DOACs and antiplatelet therapies. What are the most effective ways to achieve hemostasis in these patients?
July 26, 2022
-
Adequate Antibody Response to COVID-19 Vaccine in Patients With Monoclonal Gammopathies and Light Chain Amyloidosis
Are COVID-19 vaccines effective in producing antibody response in patients with multiple myeloma and other monoclonal gammopathies?
June 27, 2022
-
Efficacy of POC Antibody Assays After COVID-19 Infection and Potential Utility for "Immunity Passports"
This study evaluated the efficacy of two point-of-care assays for the detection of antibodies to SARS-CoV-2. Are they sufficiently accurate for providing "immunity passports" for travel?
May 27, 2022
-
HbA1c Below the Reportable Range
This case report highlights the limitations of using HbA1c as a diagnostic tool in patients with certain conditions, including, as in this patient, hemolytic anemia.
April 29, 2022
-
SARS-CoV-2 Antibody Testing: Where Are We Now?
This paper summarizes the current state of antibody testing for SARS-CoV2. What antibody tests are available, what are their limitations, and how should--and shouldn't--they be used?
March 29, 2022
-
A Persistent Positive Antibody Test in a Patient With No History of COVID-19 Infection
This cases highlights the complexity of interpreting antibody test results and potential pitfalls of using antibody testing for the diagnosis of COVID-19.
February 21, 2022
-
A Fluorescence-Based Quantitative Analysis for Total Bilirubin in Blood and Urine
The authors developed a novel, highly sensitive method to assess total bilirubin levels in serum and urine.
February 07, 2022
-
Liver Blood Tests in the Management of Suspected Choledocholithiasis
The authors developed a mathematical model based on liver blood test values and their trend over 48 hours to predict the presence of common bile duct stones.
December 24, 2021
-
Pancreatic Cancer Insights: Optimization of the Diagnostic Capacity of Tumor Biomarkers
Is the serum CA19.9/CEA ratio useful as a diagnostic tool for the differentiation of pancreatic cancer from benign pathology such as cirrhosis, pancreatitis, cholangitis, or choledocolithiasis?
November 24, 2021
-
Sky High or Undetectable? A Patient With Discordant Hemoglobin A1c
What could possibly explain this patient's implausible HbA1c level of 54.6%, as measured by HPLC, especially considering her glucose level was 106 mg/dL?
October 21, 2021
-
Clinical Utility of Midregional Proadrenomedullin in Patients With COVID-19
Might midregional proadrenomedullin, which has proven useful as a biomarker of organ failure, be a useful prognostic biomarker of in-hospital mortality in patients with COVID-19?
September 23, 2021
-
Laboratory Predictors of COVID-19 Pneumonia in Patients With Mild to Moderate Symptoms
The authors developed a laboratory model that can accurately distinguish mild-to-moderately symptomatic COVID-19 patients with pneumonia from those without pneumonia.
August 23, 2021
-
Initial Clinical Laboratory Response to COVID-19
This study surveyed laboratory professionals about their needs and experiences at the onset of the COVID-19 pandemic. What did they learn?
July 23, 2021
-
Evaluation of HCV RNA by PCR and Signal-to-Cutoff Ratios of HCV Antibody Assays for Diagnosis of HCV Infection
This study investigated whether HCV infection can be diagnosed correctly with an anti-HCV antibody test and an HCV RNA test without the addition of a recombinant immunoblot assay.
June 28, 2021
